Last reviewed · How we verify
NCT03221530
Early Intervention for Suicide Risk Among Immigrant Youth
NA trial testing Early Intervention for Suicide Risk Among Immigrant Youth in Family Conflict in 40 participants. Status unknown.
1 August 2022
Quick facts
| Lead sponsor | Massachusetts General Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 October 2019 |
| Primary completion | 1 August 2022 |
| Estimated completion | 1 August 2022 |
Drugs / interventions tested
- Early Intervention for Suicide Risk Among Immigrant Youth
- Enhanced usual care
Conditions studied
- Family Conflict — all drugs for Family Conflict →
- Suicidal Ideation — all drugs for Suicidal Ideation →
Sponsor
Massachusetts General Hospital
Who can join
Adults 12 to 15, any sex, with Family Conflict or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to develop and test a family-based preventive intervention for suicide risk among 1st and 2nd generation immigrant Latino/a adolescents. The intervention will focus on reducing suicide risk by reducing family conflict and intergenerational cultural conflict and improving parent-child communication. The investigators will first develop the 8-session preventive intervention with quantitative data from analysis of existing longitudinal studies and qualitative feedback from Latino youth and their caregivers, clinicians, administrators, and research consultants, as well as results from initial pilot testing of the intervention. The investigators will then conduct a pilot randomized trial with 40 adolescents and their families to test feasibility, acceptability, and impact on intervention targets. Successful development of the intervention would improve mental health outcomes for a growing and underserved portion of the U.S. population.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evidence Base Update of Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth.
Glenn CR, Esposito EC, Porter AC, Robinson DJ. · · 2019 · cited 115× · PMID 31046461 · DOI 10.1080/15374416.2019.1591281
Verify or expand the search:
- PubMed search for NCT03221530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Family Conflict
Currently open trials in the same condition.
- NCT07303608 — Improving Outcomes in Social Services Through Routine Outcome Monitoring and Systematic Client Feedback · NA · recruiting
- NCT06533735 — Parent Web - Support for Families With Young People · NA · recruiting
- NCT03495440 — Families of Youth with Developmental Disabilities: a Theory-Based Intervention · NA · recruiting
Other Massachusetts General Hospital trials
Trials by the same sponsor.
- NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
- NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
- NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
- NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
- NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03221530 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
- Last refreshed: 13 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03221530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing